News

Pancreatic cancer explained, Global evidence builds This innovative approach has been validated in studies across several countries, including Japan, China and Spain.
Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...
Pancreatic cancer vaccines eliminate disease in preclinical studies Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...
Now, researchers at Case Western Reserve University and Cleveland Clinic are developing vaccines targeting pancreatic cancer that could eliminate the disease, leaving a patient cancer-free.
In pancreatic cancer, metastasis is often the first sign that a patient even has cancer, and by then, the cancer has spread out of control. Researchers discovered how pancreatic cancer cells migrate ...
Actuate has set its sights on getting elraglusib approved for pancreatic cancer after the GSK-3β drug showed a three-month survival increase.
BUFFALO, N.Y. — Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors ...
Know the symptoms: Pancreatic cancerThis year, approximately 1,000 Alabama residents will be diagnosed with pancreatic cancer. With a trending increase in cases for patients under the age of 55, ...
Cases of pancreatic cancer have increased significantly among younger individuals compared with those aged 35 years and older during the past 2-plus decades, according to results of a ...
Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a study from MIT and the Dana-Farber ...
Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other ...
There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in older adults, according to a new study.